Related Experiment Video
Updated: Aug 11, 2026
11:54
Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
Summary
This study estimated chronic bronchitis prevalence in Rhodesia, finding a low 1.12% rate. Lower smoking amounts and pollution likely explain these findings compared to other populations.
Area of Science:
- Epidemiology
- Respiratory Medicine
- Public Health
Background:
- Chronic bronchitis prevalence varies globally, influenced by environmental and lifestyle factors.
- Previous research indicates higher rates in industrialized nations, necessitating studies in diverse populations.
Purpose of the Study:
- To estimate the prevalence of chronic bronchitis in an African population in Rhodesia.
- To identify potential contributing factors to chronic bronchitis rates in this specific demographic.
Main Methods:
- Utilized two British Medical Research Council-based questionnaires for data collection.
- Administered a screening questionnaire to 9768 individuals aged 5 and above.
- Conducted repeat interviews for accuracy assessment and detailed questionnaires on selected participants.
Main Results:
- Overall prevalence of chronic bronchitis was found to be 1.12%, significantly lower than in other global surveys.
- No significant increase in prevalence with age or significant differences between sexes were observed.
- Low prevalence of complications, other chest symptoms, and a non-significant difference in smoking proportions compared to controls.
Conclusions:
- Lower amounts of smoking and reduced pollution levels are probable factors for the low chronic bronchitis prevalence.
- Findings suggest environmental and lifestyle factors play a crucial role in chronic bronchitis epidemiology.
- Highlights the need for context-specific research in understanding respiratory disease prevalence.
More Related Videos
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...